Market Cap
£61.60 Billion
GBP as of July 1, 2024
US$77.93 Billion
Company | Market Cap (USD) |
---|---|
![]() |
$808.65 B |
![]() |
$350.63 B |
![]() |
$318.75 B |
![]() |
$295.34 B |
![]() |
$236.45 B |
Company | Market Cap (USD) |
---|---|
![]() |
$808.65 B |
![]() |
$622.07 B |
![]() |
$450.89 B |
![]() |
$350.63 B |
![]() |
$318.75 B |
Top 1-year algo backtest: +207.50%
$10,000 in July 2023 would now be $30,750 by following this algorithm daily at market close.
Boost your investing & swing trading... Now!
Try Disfold DeepFinance FREE
GlaxoSmithKline PLC, better known as GSK, is a pharmaceutical company. GSK manufactures products for major disease areas such as asthma, cancer, infections, diabetes, and mental health, and it also has a portfolio of vaccines. Operating in more than 115 countries, GSK is also engaged in the consumer healthcare business in oral health, pain relief, respiratory, nutrition/gastro-intestinal, and skin health categories.
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.